0      0

2020 Annual Meeting


AM20-06 - AM20-06: Cellular Therapies for SARS-CoV2


Oct 3, 2020 11:15am ‐ Oct 3, 2020 12:15pm


Credits: None available.

Standard: $25.00
Members: $20.00
Learning Objectives:
  • Discuss the latest cellular therapies advancements in the COVID-19 pandemic
  • Investigate the use of specific T cells in COVID-19 treatment
  • Discuss the importance of missing imputation for single cell sequencing (MISC) in COVID-19 analysis

Speaker(s):

Tags: cellular therapies and immunotherapies immunotherapies includes car t cells

Credits Available


AM20-06: Cellular Therapies for SARS-CoV2 Evaluation

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content